The table below provides a list of the drugs associated with non-serious adverse events identified in the scientific literature over the last week.
| Non-serious case reports | ||
| Drug name(s) | Adverse event(s) | No. of cases |
| Adalimumab | Circumscribed scleroderma, Lichen sclerosus et atrophicus | 1 |
| Anastrozole, Axitinib, Bevacizumab, Bleomycin, Cabozantinib, Capecitabine, Carboplatin, Cotrimoxazole, Cyclophosphamide, Cytarabine, Dacarbazine, Daunorubicin, Decitabine, Docetaxel, Doxorubicin, Fluorouracil, Folinic acid, Fulvestrant, Gemcitabine, Irinotecan, Letrozole, Motolimod, Paclitaxel, Pazopanib, Vinblastine, Vinorelbine | Erythrodysaesthesia | 6 |
| Ascorbic acid/paracetamol/pseudoephedrine sulfate | Exanthema | 1 |
| Avelumab | Lichenoid eruptions | 1 |
| Bleomycin | Erythema | 1 |
| Capsaicin | Erythema, Oedema, Pregnancy, Skin disorders | 1 |
| Carbamazepine, Temozolomide | Appetite disorders, Asthenia, Nausea and vomiting | 1 |
| Ceftriaxone, Metronidazole | Pruritus, Vomiting | 2 |
| Chlorhexidine, Clindamycin | Anaphylaxis | 1 |
| Chlormethine | Erythema, Hyperpigmentation, Signs symptoms and ill defined conditions, Skin disorders | 3 |
| Ciclosporin | Hyperpigmentation | 1 |
| Ciprofloxacin, Nitrofurantoin, Warfarin | Hypersensitivity | 1 |
| COVID 19 Vaccine Pfizer BioNTech | Pityriasis rosea | 2 |
| Dalbavancin | Exanthema | 1 |
| Deferasirox | Abdominal pain, Exanthema, Pain | 1 |
| Desloratadine | Atopic dermatitis | 1 |
| Desloratadine, Ebastine | Delayed hypersensitivity, Exanthema, Urticaria | 1 |
| Dimethyl fumarate, Diroximel fumarate | Acne, Flushing, Gastrointestinal disorders | 3 |
| Docetaxel, Etoposide, Gemcitabine, Paclitaxel | Anaemia, Digestive system disorders, Liver disorders | 3 |
| Doxycycline, Vandetanib | Acne, Hyperpigmentation | 1 |
| DTaP vaccine | Delayed hypersensitivity, Skin disorders | 2 |
| Dupilumab | Arthralgia | 1 |
| Dupilumab | Erythema | 1 |
| Dupilumab | False test results | 3 |
| Escitalopram, Fluoxetine | Epistaxis, Headache, Xerostomia | 1 |
| Etanercept | Injection site reactions | 1 |
| Fluorouracil | Erythrodysaesthesia | 1 |
| Fluorouracil, Gemcitabine, Gimeracil/oteracil/tegafur | Appetite disorders, Hair disorders, Malaise, Nausea | 1 |
| Folinic acid, Methotrexate | Burning sensation | 1 |
| Glecaprevir/pibrentasvir | Drug eruptions, Exanthema | 1 |
| GSK 137173A | Granuloma annulare, Skin eruptions | 1 |
| Ibuprofen | Diarrhoea | 1 |
| Imatinib, Nilotinib | Hyperglycaemia, Hypertension, Musculoskeletal pain, Nausea, Spasm, Vomiting | 1 |
| Insulin | Hypoglycaemia | 1 |
| Liraglutide | Weight loss | 1 |
| Lubiprostone, Sennosides | Clubbed fingers | 1 |
| Mefloquine | Neurological disorders, Psychiatric disorders | 1 |
| Mycophenolate mofetil, Tacrolimus | Immunodeficiency disorders, Papulosquamous skin diseases, Polyomavirus infections | 1 |
| Paclitaxel | Hypersensitivity | 1 |
| Pamidronic acid | Abdominal pain, Arthralgia, Asthenia, Chest pain, Chills, Fever | 3 |
| Paracetamol | Fixed drug eruptions | 1 |
| Pembrolizumab | Dermatitis, Lichenoid eruptions | 1 |
| Pneumococcal vaccine | Asthenia, Erythema | 2 |
| Pneumococcal vaccine | Fever, Hyperaemia, Injection site reactions, Pain | 2 |
| Prazosin | Alopecia areata | 1 |
| Rexin G | Fatigue | 1 |
| Rifabutin | Elevated aminotransferase levels | 1 |
| Rituximab | Hypersensitivity | 1 |
| Rituximab | Hypersensitivity | 2 |
| Sertraline | Gastrointestinal disorders | 1 |
| Tamoxifen | Endometrial hyperplasia | 1 |
| Thalidomide | Fatigue | 1 |
| Tildrakizumab | Injection site reactions | 1 |
| Trastuzumab emtansine | Elevated aminotransferase levels, Telangiectasis | 1 |
| Ustekinumab | Human papillomavirus infections, Warts | 1 |
| Warfarin | Haematoma | 1 |
Reference
- Non-serious case reports. Reactions Weekly 25 Aug 2021